Sale!

Liquid Biopsy. Cell Free KRAS Test Cost

Original price was: 4,800 د.إ.Current price is: 3,600 د.إ.

-25%

Liquid Biopsy: Cell-Free KRAS Test

The Liquid Biopsy: Cell-Free KRAS Test is a cutting-edge diagnostic procedure available at DNA Labs UAE, designed to detect mutations in the KRAS gene without the need for invasive surgical biopsies. Utilizing a simple blood sample, this test isolates and analyzes cell-free DNA (cfDNA) circulating in the bloodstream, which can shed light on the genetic makeup of cancer cells.

KRAS mutations are pivotal in the development and progression of various cancers, including colorectal, lung, and pancreatic cancers. Early and accurate detection of these mutations can significantly impact treatment decisions and patient outcomes, offering a personalized approach to cancer therapy.

Priced at 3600 AED, the Cell-Free KRAS Test at DNA Labs UAE represents a significant advancement in non-invasive cancer diagnostics, providing patients and healthcare providers with crucial genetic information swiftly and safely, without the discomfort and complications associated with traditional biopsy methods.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

Liquid Bx. Cell Free KRAS Test

At DNA Labs UAE, we offer the Liquid Bx. Cell Free KRAS Test for AED 3600.0. This molecular diagnostic test is used to detect mutations in the KRAS gene in cell-free DNA (cfDNA) found in the blood. KRAS mutations are commonly found in various types of cancer, including colorectal, lung, and pancreatic cancer.

Test Details

The Liquid Bx. Cell Free KRAS Test utilizes a technology called digital PCR (polymerase chain reaction) to amplify and detect specific KRAS gene mutations. This test can provide information about the presence or absence of KRAS mutations, as well as the specific type of mutation present.

The test is typically used in cancer patients to help guide treatment decisions. Knowing the KRAS mutation status can help determine the most appropriate treatment options, especially in relation to targeted therapies such as EGFR inhibitors.

Sample Collection and Delivery

The Liquid Bx. Cell Free KRAS Test requires a simple blood draw, making it a convenient and accessible option for patients. Once the sample is collected, it is placed in a Streck Tube and sent to our laboratory. The test results are typically delivered within 5-7 days.

Pre Test Information

The Liquid Bx. Cell Free KRAS Test can be done with a doctor’s prescription. However, please note that the test is not applicable for surgery and pregnancy cases or individuals planning to travel abroad.

Test Department

The Liquid Bx. Cell Free KRAS Test is conducted in our Genetics Test Department, overseen by our team of oncologists and trained healthcare professionals.

Conclusion

The Liquid Bx. Cell Free KRAS Test offered by DNA Labs UAE is a non-invasive and reliable method for detecting KRAS gene mutations in cancer patients. By providing valuable information about the mutation status, this test helps personalize treatment plans and improve patient outcomes. Contact us today to learn more about this test and how it can benefit you or your loved ones.

Test Name Liquid Bx. Cell Free KRAS Test
Components Streck Tube
Price 3600.0 AED
Sample Condition Peripheral Blood
Report Delivery 5-7 days
Method Droplet Digital PCR
Test type Genetics
Doctor Oncology
Test Department:
Pre Test Information Liquid Bx. Cell Free KRAS can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad.
Test Details

Liquid Bx. Cell Free KRAS is a molecular diagnostic test used to detect mutations in the KRAS gene in cell-free DNA (cfDNA) found in the blood. KRAS mutations are commonly found in various types of cancer, including colorectal, lung, and pancreatic cancer.

Liquid Bx. Cell Free KRAS utilizes a technology called digital PCR (polymerase chain reaction) to amplify and detect specific KRAS gene mutations. This test can provide information about the presence or absence of KRAS mutations, as well as the specific type of mutation present.

The test is typically used in cancer patients to help guide treatment decisions. KRAS mutations can affect the response of cancer cells to certain targeted therapies, such as EGFR inhibitors. Therefore, knowing the KRAS mutation status can help determine the most appropriate treatment options for patients.

Liquid Bx. Cell Free KRAS is a non-invasive test that requires a simple blood draw, making it a convenient and accessible option for patients. It is performed in a laboratory setting by trained healthcare professionals. The results of the test can be used by oncologists and other healthcare providers to personalize treatment plans for cancer patients.